Home Tags FDA

Tag: FDA

Seattle Genetics. Exhibition booth during the 2019 annual meeting of the American Society of Medical Oncology (ASCO).

Biologics License Application and Priority Review for Enfortumab Vedotin in Urothelial...

Peter Hofland, Ph.D -

FDA Approves Pfizer’s Biosimilar rituximab-pvvr for Certain Cancers and Autoimmune Conditions

Peter Hofland, Ph.D -

United States and Europe Reach Milestone Agreement on Mutual Recognition of...

Danielle Garcia -
Child embracing ill mother

FDA Approves Venetoclax as a Chemotherapy-Free Combination in Previously Untreated CLL

Peter Hofland, Ph.D -

Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices?

Eric T. Rosenthal -

Cancer Research Organizations Recommend Changes to Reduce Barriers to Clinical Trial...

Peter Hofland, Ph.D -

Why Do We Need a Right-to-Try Bill in America?

Jane Orient -

New York Times Editorial Advocates for Policies that Could Hurt Patients

Ellen Sigal -

Why Academia Wasn’t Ready to Build Big Data Systems – A...

Eric T. Rosenthal -

Investigational Pediatric Cancer Drug Shows 93% Response Rate

Peter Hofland, Ph.D -
12Page 1 of 2

LATEST

© 2019 Sunvalley Communication, LLC. All Rights Reserved.